ArriVent BioPharma, Inc. (AVBP) vs GoodRx Holdings, Inc. (GDRX)
A side-by-side comparison of ArriVent BioPharma, Inc. and GoodRx Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AVBP
ArriVent BioPharma, Inc.
$13.03HealthcareDelayed quote: Oct 6, 2026, 11:25 AM EDT
GDRX
GoodRx Holdings, Inc.
$3.33HealthcareDelayed quote: Oct 6, 2026, 11:25 AM EDT
Total return — AVBP vs GDRX
growth of $100 · dividends reinvested · last 3yAVBP +42.3% (+12.5%/yr)GDRX -48.2% (-19.7%/yr)AVBP compounded faster over this window
AVBP GDRX
AVBP vs GDRX: by the numbers
- •GDRX is the larger company ($1.15B vs $607M market cap).
- •GDRX is profitable (2.07% net margin) while AVBP runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | AVBP | GDRX |
|---|---|---|
| P/E ratio | N/A | 78.24 |
| P/S ratio | N/A | 1.47 |
| P/B ratio | 1.65 | 1.78 |
| EV / EBITDA | N/A | 8.25 |
| FCF yield | N/A | 12.65% |
Profitability
| Metric | AVBP | GDRX |
|---|---|---|
| Gross margin | 0.00% | 88.05% |
| Operating margin | 0.00% | 10.25% |
| Net margin | 0.00% | 2.07% |
| ROE | -44.63% | 2.51% |
| ROIC | -47.96% | 3.72% |
Growth (annualized)
| Metric | AVBP | GDRX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 4.47% |
| FCF CAGR (5Y) | N/A | 11.72% |
| Total return CAGR (5Y) | N/A | -39.98% |
Frequently asked
- Is AVBP or GDRX more profitable?
- GDRX runs the higher net margin — AVBP at 0.00% versus GDRX at 2.07%.
Go deeper
Dig into the metrics
GoodRx P/E ratioArriVent BioPharma ROEGoodRx ROEArriVent BioPharma operating marginGoodRx operating marginArriVent BioPharma revenue growthGoodRx revenue growthArriVent BioPharma free cash flowGoodRx free cash flow
ArriVent BioPharma & GoodRx appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.